Balanced news tone
News Sentiment
LIVN sentiment intelligence
LivaNova PLC news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
75/100 classification confidence.
directly relevant articles
high-authority source matches
-1.3% over one week, +4.0% over four weeks, trend active, and materially above fair value.
LIVN Maintains by Mizuho -- Price Target Raised to $95.00
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
LIA Forecast — Price Target — Prediction for 2027
This article provides a forecast for LivaNova Plc (LIA) stock, including analyst price targets, ratings, and financial data. It details the company's past earnings and revenue, future estimates, and historical stock performance. The article also answers frequently asked questions
- Tone
- Positive 64/100
- Event
- Earnings
- Published
- 26 Jun 2026 07:10
- Source
- TradingView
How New OSA PolySync Data Could Shape LivaNova’s (LIVN) Neuromodulation Investment Narrative
LivaNova (LIVN) recently presented new clinical data for its PolySync programming algorithm, showing an 84.5% response rate in moderate to severe Obstructive Sleep Apnea patients. This data reinforces the company's neuromodulation platform and its investment in next-generation OS
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 26 Jun 2026 02:09
- Source
- Sahm
Press Release: LivaNova to Announce Second-Quarter 2026 Results
LivaNova (NASDAQ: LIVN) is scheduled to announce its second-quarter 2026 financial results after the market closes on Tuesday, August 4, 2026. The company will host a conference call and webcast on Wednesday, August 5, 2026, at 9:00 a.m. EDT to discuss these results.
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Jun 2026 00:09
- Source
- Moomoo
LivaNova to Announce Second-Quarter 2026 Results
LivaNova PLC (Nasdaq: LIVN) will host a conference call on Wednesday, August 5, 2026, at 1 p.m. London time (8 a.m. Eastern Daylight Time) to discuss its second-quarter 2026 financial results. The company plans to release its results prior to the call, which will be accessible vi
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 24 Jun 2026 12:40
- Source
- Business Wire
LivaNova Reports Improved OSA Outcomes With PolySync Programming
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 14:14
- Source
- Zacks
LivaNova's PolySync Algorithm Supports Improvement in Sleep Apnea Treatment Response Rate
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 16:08
- Source
- MT Newswires
LivaNova Demonstrates 84.5% Cumulative Response Rate with PolySync Programming in OSPREY Study for Obstructive Sleep Apnea
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 14:57
- Source
- Business Wire
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jun 2026 07:00
- Source
- StockStory
LivaNova (LIVN) Stock Valuation Check After Strong Recent Shareholder Returns
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- Market source
Jette Nygaard-Andersen Joins LivaNova Board as a New Director
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 17:44
- Source
- Business Wire
LivaNova Stock: My Targets Hold, Maintaining My Rating For 2H26 (NASDAQ:LIVN)
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 10 Jun 2026 07:00
- Source
- Seeking Alpha
Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 May 2026 07:00
- Source
- Market source
LivaNova (LIVN) Upgraded to Buy: Here's What You Should Know
- Tone
- Positive 76/100
- Event
- Analyst action
- Published
- 11 May 2026 16:00
- Source
- Zacks
Why LivaNova (LIVN) Is Up 18.0% After Boosting 2026 Outlook And Winning Aura6000 FDA Approval
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 09 May 2026 07:00
- Source
- Market source
LivaNova (LIVN) Profit Return And 33.8x P E Test Bullish Narratives
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- simplywall.st
LivaNova Q1 2026 slides: double-digit growth drives guidance raise
- Tone
- Positive 82/100
- Event
- Guidance
- Published
- 06 May 2026 07:00
- Source
- Investing.com
LivaNova PLC Q1 2026 Earnings Call Summary
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 May 2026 07:00
- Source
- Market source
LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 May 2026 07:00
- Source
- Market source
LIVANOVA ($LIVN) Releases Q1 2026 Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 May 2026 07:00
- Source
- Quiver Quantitative
Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Apr 2026 07:00
- Source
- Market source
A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks’ Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Apr 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Apr 2026 07:00
- Source
- Market source
LivaNova (LIVN) Announces FDA Approval of aura6000 System for Obstructive Sleep Apnea
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 25 Mar 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Mar 2026 07:00
- Source
- Market source
LivaNova’s Aura6000 FDA Win Reshapes Obstructive Sleep Apnea Opportunity
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Mar 2026 07:00
- Source
- simplywall.st
LivaNova wins FDA Approval for sleep apnea treatment device
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 19 Mar 2026 07:00
- Source
- Medical Economics
Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Mar 2026 07:00
- Source
- StockStory
Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Mar 2026 07:00
- Source
- Market source
Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 Mar 2026 07:00
- Source
- Market source
A Look At LivaNova (LIVN) Valuation After Earnings Show Growth Guidance And A Swing To Net Loss
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 03 Mar 2026 08:00
- Source
- Market source